大麻劇吐症
外觀
大麻劇吐症 | |
---|---|
![]() | |
大麻劇吐症患者通常會透過熱水淋浴來緩解部分症狀[1][2] | |
症狀 | 噁心、嘔吐和痙攣性腹痛[3] |
併發症 | 腎功能衰竭 |
病因 | 長期過量使用大麻[3] |
診斷方法 | 依症狀診斷[1] |
鑑別診斷 | 週期性嘔吐症候群[4] |
治療 | 停止使用大麻、沖或泡個熱水澡[1] |
藥物 | 辣椒素 氟哌啶醇 昂丹司瓊[1] |
分類和外部資源 | |
醫學專科 | 消化科 |
大麻劇吐症(Cannabinoid hyperemesis syndrome,CHS)是一種因使用大麻而引起的反覆噁心、嘔吐和痙攣性腹痛[5][6]。沖或泡個熱水澡可能會暫時改善症狀[7]。併發症包括可能腎功能衰竭、電解質不平衡以及熱水引起的皮膚燒傷[7]。至少有兩例死亡與它有關[7] [8] [9]。
通常需要每天或每周使用大麻數年才會發病[7] [5] [10]。可能機轉仍不清楚,目前已有幾種可能的假說[7]。依症狀診斷[7]。在診斷前,此病症通常已持續一段時間[7]。另一個有類似症狀的可能疾病是週期性嘔吐症候群[7]。
最終的治療包括停止使用大麻[7]。可能需要兩周以上才會看到效果[7]。嘔吐期以支持性治療與主[7]。有初步證據顯示,急性發作期,可以服用氟哌啶醇並在腹部塗抹辣椒素乳膏[7] [5]。
影響人數仍不清楚[11]。在美國,因反覆嘔吐而去急診的患者中,約有 6% 患有此症[7]。雖然大麻使用合法化似乎不會影發生率,但大麻商業化已使發生率上升[12]。2004 年首次描述此症候群,簡易版的診斷標準於 2009 年出版[13] [14]。
參考文獻
[編輯]- ^ 1.0 1.1 1.2 1.3 Korn F, Hammerich S, Gries A. [Cannabinoid hyperemesis as a differential diagnosis of nausea and vomiting in the emergency department]. Der Anaesthesist (Review). February 2021, 70 (2): 158–160. PMC 7850992
. PMID 33090239. doi:10.1007/s00101-020-00850-2 (德語).
- ^ Nourbakhsh M, Miller A, Gofton J, Jones G, Adeagbo B. Cannabinoid Hyperemesis Syndrome: Reports of Fatal Cases. Journal of Forensic Sciences (Wiley). January 2019, 64 (1): 270–274. PMID 29768651. S2CID 21718690. doi:10.1111/1556-4029.13819
.
- ^ 3.0 3.1 Sullivan S. Cannabinoid hyperemesis. Canadian Journal of Gastroenterology. May 2010, 24 (5): 284–285. PMC 2886568
. PMID 20485701. doi:10.1155/2010/481940
.
- ^ Galli JA, Sawaya RA, Friedenberg FK. Cannabinoid hyperemesis syndrome. Current Drug Abuse Reviews. December 2011, 4 (4): 241–249. PMC 3576702
. PMID 22150623. doi:10.2174/1874473711104040241.
- ^ 5.0 5.1 5.2 Sorensen CJ, DeSanto K, Borgelt L, Phillips KT, Monte AA. Cannabinoid Hyperemesis Syndrome: Diagnosis, Pathophysiology, and Treatment-a Systematic Review. Journal of Medical Toxicology. March 2017, 13 (1): 71–87. PMC 5330965
. PMID 28000146. doi:10.1007/s13181-016-0595-z.
- ^ DeVuono MV, Parker LA. Cannabinoid Hyperemesis Syndrome: A Review of Potential Mechanisms. Cannabis and Cannabinoid Research. June 2020, 5 (2): 132–144. PMC 7347072
. PMID 32656345. doi:10.1089/can.2019.0059.
- ^ 7.00 7.01 7.02 7.03 7.04 7.05 7.06 7.07 7.08 7.09 7.10 7.11 7.12 Chocron Y, Zuber JP, Vaucher J. Cannabinoid hyperemesis syndrome. BMJ. July 2019, 366: l4336. PMID 31324702. S2CID 198133206. doi:10.1136/bmj.l4336.
- ^ Rudavsky, Shari. He loved weed. Then the vomiting began. Months later, he died. USA TODAY. [2 February 2020]. (原始內容存檔於1 November 2020).
- ^ Soota, Kaartik; Lee, Ye-Jin; Schouweiler, Katie; Keeney, Matthew; Nashelsky, Marcus; Holm, Adrian. Cases of Death Secondary to Cannabinoid Hyperemesis Syndrome: 2217. American Journal of Gastroenterology: S1063. October 2016 [2 February 2020]. (原始內容存檔於15 January 2021).
- ^ Chu, F; Cascella, M. Cannabinoid Hyperemesis Syndrome.. StatPearls. January 2023 [2023-05-25]. PMID 31751105. (原始內容存檔於2023-01-04).
- ^ Lu, ML; Agito, MD. Cannabinoid hyperemesis syndrome: Marijuana is both antiemetic and proemetic.. Cleveland Clinic Journal of Medicine. July 2015, 82 (7): 429–34. PMID 26185942. doi:10.3949/ccjm.82a.14023.
- ^ Myran, Daniel Thomas; Roberts, Rhiannon; Pugliese, Michael; Taljaard, Monica; Tanuseputro, Peter; Pacula, Rosalie Liccardo. Changes in Emergency Department Visits for Cannabis Hyperemesis Syndrome Following Recreational Cannabis Legalization and Subsequent Commercialization in Ontario, Canada. JAMA Network Open. 16 September 2022, 5 (9): e2231937. doi:10.1001/jamanetworkopen.2022.31937.
- ^ Allen, J H; De Moore, GM; Heddle, R; Twartz, JC. Cannabinoid hyperemesis: Cyclical hyperemesis in association with chronic cannabis abuse. Gut. 2004, 53 (11): 1566–70. PMC 1774264
. PMID 15479672. doi:10.1136/gut.2003.036350.
- ^ Sontineni, Siva-P; Chaudhary, S; Sontineni, V; Lanspa, SJ. Cannabinoid hyperemesis syndrome: Clinical diagnosis of an underrecognized manifestation of chronic cannabis abuse. World Journal of Gastroenterology. 2009, 15 (10): 1264–6. PMC 2658859
. PMID 19291829. doi:10.3748/wjg.15.1264.
延伸閱讀
[編輯]- Deceuninck E, Jacques D. Cannabinoid hyperemesis syndrome: a review of the literature. Psychiatria Danubina (Review). September 2019, 31 (Suppl 3): 390–394. PMID 31488758.
- Khattar N, Routsolias JC. Emergency Department Treatment of Cannabinoid Hyperemesis Syndrome: A Review. American Journal of Therapeutics (Review). 2018, 25 (3): e357–e361. PMID 28953512. S2CID 9800385. doi:10.1097/MJT.0000000000000655
.
- Leu N, Routsolias JC. Cannabinoid Hyperemesis Syndrome: A Review of the Presentation and Treatment. Journal of Emergency Nursing (Review). May 2021, 47 (3): 483–486. PMID 33712244. S2CID 232218693. doi:10.1016/j.jen.2020.11.006.
- Sanders L. It Was Her Third Visit to the E.R. What Was Causing Her Abdominal Pain?. The New York Times. 2022-11-16 [2022-11-25]. ISSN 0362-4331. (原始內容存檔於2025-01-15) (美國英語).
外部連結
[編輯]